Alternative Biomedical Solutions Gp LLC is categorized under Medical Labs in Dallas, TX and active since 2005.
Alternative Biomedical Solutions Gp LLC was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Clifton Wright at the company’s headquarters by writing to 2412 Arbuckle Court, Dallas, Texas TX 75229 or by phoning (972) 241-1338. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alternative Biomedical Solutions Gp LLC |
| Contact Person: | Clifton Wright |
| Address: | 2412 Arbuckle Court, Dallas, Texas 75229 |
| Phone Number: | (972) 241-1338 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Alternative Biomedical Solutions Gp LLC was started in 2005 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Clifton Wright for inquiries that concern Alternative Biomedical Solutions Gp LLC by calling the company number (972) 241-1338, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Alternative Biomedical Solutions Gp LLC can be found at the coordinates 32.884928,-96.895191 as well as the street address 2412 Arbuckle Court in Dallas, Texas 75229.
For its online presence, you may visit Alternative Biomedical Solutions Gp LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.